Enjoy a flat 15% OFF on all 2025 Global Market Reports until March 31st! Use code FY25SAVE to save big—don’t miss out!

How has the pancreaze (pancrelipase) market grown in recent years?

The market for pancreaze (pancrelipase) has seen robust growth over the recent past. The market that’s standing at $1566.86 million in 2024 is predicted to escalate to $1660.16 million in 2025, mirroring a compound annual growth rate (CAGR) of 6.0%. The historic growth is credited to factors like an increasing number of exocrine pancreatic insufficiency (EPI) cases, a growing older demographic, better treatment alternatives, a rise in incidences of pancreatic cancer, and the expansion of healthcare services on a global scale.

How is the pancreaze (pancrelipase) market size expected to evolve during the forecast period?

In the coming years, the pancreaze (pancrelipase) market is poised to experience robust growth, reaching $2063.36 million in 2029 with a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this anticipated growth include the increasing incidence of pancreatic diseases, ongoing research and clinical trials, expanding access to global healthcare, enhancements in healthcare infrastructure, and governmental policies and repayment schemes. The forecast period is likely to see major advancements such as improvements in enzyme delivery systems, technological progression, digital health solutions integration, escalation in partnerships, and the genesis of enteric-coated formulations.

Get your pancreaze (pancrelipase) market report here!

https://www.thebusinessresearchcompany.com/report/pancreaze-pancrelipase-global-market-report

Which key drivers are propelling the pancreaze (pancrelipase) market’s growth?

The increasing number of cystic fibrosis incidences are anticipated to spur the expansion of the pancreaze (pancrelipase) market in the future. Cystic fibrosis, a genetic disorder, disrupts the function of lungs, digestive system, and other organs by inducing the production of thick and sticky mucus, which results in blockages, infections, and function impairments. The surge in cystic fibrosis cases can be attributed to enhanced awareness, superior diagnostic techniques, and comprehensive genetic screening programs, all of which are identifying additional cases, encompassing milder forms that were previously undiagnosed. Pancreaze (pancrelipase) is utilized in the treatment of cystic fibrosis, assisting with digestion by supplementing the enzymes that the pancreas isn’t capable of producing effectively, which facilitates nutrient absorption from food and optimizes overall nutritional well-being. For example, the UK-based Cystic Fibrosis Trust, a charity committed to providing support to individuals with cystic fibrosis, reported in October 2024 that the number of registered cystic fibrosis patients grew from 11,148 in 2022 to 11,318 in 2023, showing a 1.5% increase in patient registrations year-over-year. Consequently, the surge in cystic fibrosis cases is fueling the expansion of the pancreaze (pancrelipase) market.

What are the market segments in the pancreaze (pancrelipase) industry?

The pancreaze (pancrelipase) market covered in this report is segmented –

1) By Type: Capsule, Tablet

2) By Age: Children, Adults, Geriatrics

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By Application: Chronic Pancreatitis, Cystic Fibrosis, Other Applications

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20173&type=smp

Which leading companies are shaping the growth of the pancreaze (pancrelipase) market?

Major companies operating in the pancreaze (pancrelipase) market include AbbVie Inc.

What key trends are currently impacting the pancreaze (pancrelipase) market’s development?

One notable trend in the pancreaze (pancrelipase) industry is the heightened attention towards clinical proof to validate drug effectiveness, predominantly through clinical trial findings. Such information is instrumental in streamlining regulatory approval procedures, enhancing patient results, and reinforcing a medicine’s competitive stance in the market. For instance, in May 2024, Vivus, Inc., a biopharmaceutical entity based in the US, unveiled fresh clinical trial findings showcasing the effectiveness of PANCREAZE (pancrelipase) in maintaining weight in chemotherapy patients suffering from pancreatic ductal adenocarcinoma (PDAC) who are experiencing cachexia and exocrine pancreatic insufficiency (EPI). The data also points towards potential advantages of PANCREAZE in decreasing stool frequency and improving stool texture. This research was performed as an investigator-driven trial by scientists at Cedars-Sinai Medical Center and the Samuel Oschin Cancer Center.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20173

Which geographic areas are influencing the growth of the pancreaze (pancrelipase) market?

North America was the largest region in the pancreaze (pancrelipase) market in 2024. The regions covered in the pancreaze (pancrelipase) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Digestive Enzymes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report

Digestive Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digestive-health-global-market-report

Digestive Health Supplements Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digestive-health-supplements-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: